Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents
Clicks: 246
ID: 272838
2021
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
30.0
/100
217 views
24 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
The outbreak of COVID-19 from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread all over the world with tremendous morbidity and mortality in the elderly. In-hospital treatment addresses the multifaceted nature of the illness including initial viral replication, cytokine storm, …
| Reference Key |
pe2021medicalearly
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Alexander PE;Armstrong R;Fareed G;Lotus J;Oskoui R;Prodromos C;Risch HA;Tenenbaum HC;Wax CM;Dara P;McCullough PA;Gill KK;; |
| Journal | medical hypotheses |
| Year | 2021 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
aged
nursing homes
outpatients
covid-19*
sars-cov-2*
pmid:34130113
pmc8178530
doi:10.1016/j.mehy.2021.110622
paul e alexander
robin armstrong
kulvinder k gill
hydroxychloroquine
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.